GET THE APP

Pharmacotherapy Prescribed for Oral Candidiasis in an Outpatient Population-An Institutional Study

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research - (2021) Volume 9, Issue 10

Pharmacotherapy Prescribed for Oral Candidiasis in an Outpatient Population-An Institutional Study

Deepika R and Lakshminarayanan Arivarasu*

*Correspondence: Lakshminarayanan Arivarasu, Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India, Email:

Author info »

Abstract

Introduction: Oral candidiasis is one of the most common human opportunistic fungal infections caused by C.albicans of the oral cavity. The incidence of candidiasis is associated with some predisposing factors that include the use of dentures, xerostomia, and prolonged therapy with Antibiotics and found as a major clinical feature with HIV. This pathology has a wide variety of treatments which has been studied until these days. Objective: The aim of this study is to evaluate the prevalence of drugs prescribed for candidiasis patients in an outpatient population. Materials and methods: A cross sectional study was conducted among 67 candidiasis patients at the clinic of Saveetha dental college. The data was collected from Dias and is statistically analysed using spss software. Results and discussion: From the results obtained we conclude that males are more prone to candidiasis than females (68.66%) due to the predisposing factors and causes. The drugs commonly prescribed for candidiasis were clotrimazole (64.18%) as a topical antifungal drug than amphotericin B (4.48) and fluconazole (46.27%) as a systemic antifungal drug than ketoconazole due to their benefits. Conclusion: The study provides the prevalence of oral candidiasis among the out patients and assesses the drug of choice for the treatment of oral candidiasis .Thus this study may guide to establish a better clinical approach and helps in assessing the treatment of choice for oral candidiasis.

Keywords

Clotrimazole, Fluconazole, Ketoconazole, Oral candidiasis, Pharmacotherapy

Introduction

Oral candidiasis is one of the most common human opportunistic fungal infections caused by Candida albicans of the oral cavity. The oral Candidiasis can also be termed as oral thrush [1]. Candida albicans (C. albicans) represents around 80% of contaminations and they tend to build as colonies either alone or as groups with other species, including Candida glabrata and Candida tropicalis [2]. The oral candidiasis is commonly seen among children, people with immune deficiency and those who use steroid sprays for asthma [3]. The incidence of candidiasis is also associated with some predisposing factors that include the use of denture wearers, xerostomia, smoking, poor oral hygiene maintenance, prolonged therapy with Antibiotics, and patients under the medication of immunosuppressive agents for a long period [4]. The oral candidiasis is normally characterised by creamy whitish patches seen on the buccal cheek region, tongue, tonsils and sometimes over the palatal region of the oral cavity [5]. People with oral candidiasis may also experience bad breath, burning mouth syndrome, dryness, abnormality of taste, difficulty in swallowing, or redness. It is acknowledged that the histopathological evidence of a given clinical feature, can also provide an exact evaluation of the findings [6]. Candidiasis is typically mild and rarely causes serious problems [7]. But in people with weakened immune systems, it can spread to other parts of the body and cause potentially serious complications. Candidiasis is found as a major clinical feature with HIV [8]. This pathology has a wide variety of treatments which has been studied until recently. Candidiasis in the mouth, throat, or esophagus is usually treated with antifungal medications. These medications include clotrimazole, fluconazole, miconazole, or nystatin [9].

Previous studies have also mentioned that candida species cause oral thrush when a patient's host immunity becomes disrupted which is due to the local, secondary to oral corticosteroid use [10]. The candidiasis has to be confirmed histopathologically as to differentiate from other clinical diagnoses such as oral hairy leukoplakia, angioedema, aphthous stomatitis, herpes gingivostomatitis, herpes labialis, measles (Koplik spots), Steven-Johnsons syndrome, histiocytosis, blastomycosis, lymphohistiocytosis, syphilis and streptococcal pharyngitis was highlighted by Ashman in his article [11,12]. A study by Aun suggested that oral candidiasis prevalent in immunocompetent host, can lead to certain complication that incorporate dysphagia, respiratory distress and candida esophagitis, which is particularly a common complication of oral candidiasis in those with HIV/AIDS [13].

The lacunae of this study include the sample size which was taken within a limited geographical area. The other factors also include that there is no restriction of age mentioned and the study only concentrated on the people who were affected with Candidiasis .The challenges faced also include that patients are restricted to a geographic location, being an institutional study in an outpatient population. In some cases, the external factors can also cause an impact and safety measures have to be ensured for prevention. Our team has extensive knowledge and research experience that has translate into high quality publications [1433]. Thus the aim of the study was to evaluate the prevalence of drugs prescribed for candidiasis patients in an outpatient population.

Material and Method

A cross sectional study was conducted in an outpatient patient population of Saveetha dental college, Chennai, India. Ethical approval was obtained from the international review board prior to the start of the study. The study consists of one reviewer, one accessor and one guide.

Inclusion criteria:

This study included the patients who reported to Saveetha dental college with Candidiasis.

Exclusion criteria:

The patients reported with other dental complications and maxillofacial surgery was also excluded from this study.

Sampling technique

The study was based on a random sampling method. To minimise the sampling bias all the cases were reviewed properly and included.

Data collection and tabulation

Data collection was done using the patient database with the time frame work of 1 January 2020 to February 2021. The data was obtained from DIAS (Dental information Archiving software), after assessment in the university patient data registry, case records of 67 patients clinically diagnosed with Candidiasis were included and evaluated in the study. Cross verification of the data was done by the reviewer. The collection data was tabulated based on the following parameters:

• Patient chief complaint –Candidiasis.

• Medications prescribed for those patients.

• Review of those patients.

Statistical analysis

The collected data was compiled using excel and data analysis was carried out using SPSS software version 21. Chi square test was used for test associations between categorical variables. Variables were expressed in terms of frequency, percentage, bar graphs were plotted and the p value < than 0.05 was considered as significant.

Results

Results are explained through Figures (Figures 1 to Figure 3).

advances

Figure 1. Represents the bar graph of gender comparison among the patients reported with oral candidiasis. 68.66% were males and 31.34% were females.

advances

Figure 2. Depicts the bar graph association between gender and the topical antifungal medications prescribed for oral candidiasis patients. Gender is plotted along the X axis and the percentage of topical antifungal agents prescribed for oral candidiasis patients are plotted along Y axis. 64.18% of the male patients were prescribed clotrimazole and 31.34% of the females were prescribed clotrimazole (green).Whereas only 4.48% of the males were prescribed for amphotericin b injection (blue). The chi square test was evaluated showing a negative correlation of p value p=0.332 (p>0.05). Statistically not significant.

advances

Figure 3. Illustrates the comparison graph between gender and the systemic antifungal medications. Gender was plotted along the X axis and the percentage of systemic antifungal agents prescribed to oral candidiasis patients were plotted along the Y axis. 23.88% of the female patients were prescribed with fluconazole (blue) and 7.46% of the females were prescribed with ketoconazole (green). Whereas 46.27% of the males were prescribed fluconazole and 22.39% of the male patients were prescribed ketoconazole. The chi square test was evaluated for this graph which showed a positive correlation of p value p=0.031 (p>0.05). Statistically significant.

Discussion

From the results we observe that males (68.66%) were prevalently affected with oral candidiasis than females (31.34%). Males have been more commonly involved with habits such as smoking, drinking, poor oral hygiene maintenance, minimum visit to dentists and sometimes due to their drug intake that causes immunosuppression. This proves to be a major risk and thus owing to oral candidiasis prevalent among males [34]. The patients with oral candidiasis have to be treated effectively to prevent the recurrence of the infection. As a topical antifungal agent it was found that clotrimazole (64.18%) was the most predominant medication prescribed among the patients. Clotrimazole lozenge is absorbed by the body and begins to treat oral thrush within 30 to 60 minutes after taking the dose by the patients. Most patients begin to feel relief in about a week, but it takes 2 weeks to completely get rid of the fungus causing your infection [35,36]. Many studies also suggest clotrimazole as the most common drug to prescribe for oral candidiasis than the oral drugs such as miconazole, or nystatin [37]. The systemic antifungal medications commonly prescribed include fluconazole (46.27%) and ketoconazole (22.39%). Many authors have focused on evaluating the efficacy and safety of fluconazole oral solution for the treatment of oropharyngeal candidiasis, especially pseudomembranous type. Further, when dealing with immunocompromised patients, such as HIVinfected, or cancerous patients, fluconazole and ketoconazole drugs have good effects when doubling the dose [38]. The dose was individualized for each patient depending on the severity and type of candidiasis. In recent years many dentists prescribe chlorhexidine mouthwashes along with antifungal agents [39]. Chlorhexidine works as an antimicrobial agent and also helps in preventing Candida species [40]. In addition the dentist has to ensure the predisposing factors of a patient reporting for dental treatment, also proper oral hygiene instructions along with instructing them to remove the dentures at night and placing in water, thereby will benefit the removal of the biofilm layer generated in the prosthetic surface. Thus, Regular oral and dental hygiene with periodic oral examination will prevent most cases of oral candidiasis, so it is needed to make the patient aware of oral hygiene measures.

Conclusion

From this study we observe that oral candidiasis is more prevalent among the males in the study population. Clotrimazole and fluconazole were found to be the most common drugs prescribed with less adverse effects for the treatment of oral candidiasis. Hence preventive measures, campaigns and dental awareness have to be created among the common people to control and resist the occurrence of the oral candidiasis. Thus this study may guide to establish a better clinical approach and helps in assessing the treatment of choice for oral candidiasis.

References

Author Info

Deepika R and Lakshminarayanan Arivarasu*

Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India
 

Citation: Deepika R, Lakshmi Narayanan, Pharmacotherapy Prescribed for Oral Candidiasis in an Outpatient Population-An Institutional Study, J Res Med Dent Sci, 2021, 9(10): 194-198

Received Date: Sep 09, 2021 / Accepted Date: Oct 12, 0021 /

cappadocia tours
cappadocia hotels
cappadocia balloon flights

paper.io

agar io

wormax io